Zinc salts provide a novel, prolonged and rapid inhibition of gastric acid secretion
OBJECTIVES: The overproduction of acid and the associated illnesses linked to
hypersecretion have a lifetime prevalence of 25–35% in the United States. Although a …
hypersecretion have a lifetime prevalence of 25–35% in the United States. Although a …
Dietary sugar/starches intake and Barrett's esophagus: a pooled analysis
Barrett's esophagus (BE) is the key precursor lesion of esophageal adenocarcinoma, a
lethal cancer that has increased rapidly in westernized countries over the past four decades …
lethal cancer that has increased rapidly in westernized countries over the past four decades …
[HTML][HTML] Evaluation of temperament–based diet education on quality of life in patients with GERD
H Chamanzari, SA Saqebi, K Harati… - Evidence Based …, 2014 - ebcj.mums.ac.ir
Background: Gastroesophageal reflux disease is one of the most common chronic disorders
of the digestive system. Almost anyone experiences heartburn or reflux (the two main …
of the digestive system. Almost anyone experiences heartburn or reflux (the two main …
Does this patient have oesophageal motility abnormality or pathological acid reflux?
BACKGROUND AND AIMS.: The diagnostic values of particular symptoms centred on
oesophagus, among patients with suspected oesophageal motility abnormality or …
oesophagus, among patients with suspected oesophageal motility abnormality or …
Gastroesophageal reflux disease and odds of head and neck squamous cell carcinoma in N orth C arolina
EL Busch, JP Zevallos, AF Olshan - The Laryngoscope, 2016 - Wiley Online Library
Objectives/Hypothesis Exposure to excess gastric acid resulting from gastroesophageal
reflux disease, also known as acid reflux or heartburn, might contribute to initiation of head …
reflux disease, also known as acid reflux or heartburn, might contribute to initiation of head …
Fast acting inhibitor of gastric acid secretion
JP Geibel, P Kirchhoff - US Patent 11,510,894, 2022 - Google Patents
2004/0126333 A1 7/2004 Galli et al. 2004/0180850 A1* 9/2004 Natunen et al. 514/54
2004/0248942 A1* 12/2004 Hepburn et al. 514/338 2005/0147675 A1* 7/2005 Petrus …
2004/0248942 A1* 12/2004 Hepburn et al. 514/338 2005/0147675 A1* 7/2005 Petrus …
Fast acting inhibitor of gastric acid secretion
JP Geibel, P Kirchhoff - US Patent 8,512,761, 2013 - Google Patents
The present invention relates to the use of pharmaceutically acceptable Zinc salts, in
particular, Zinc chloride and Zinc acetate alone or optionally, in combination with one or …
particular, Zinc chloride and Zinc acetate alone or optionally, in combination with one or …
Compositions with enhanced bioavailability and fast acting inhibitor or gastric acid secretion
JP Geibel, P Kirchhoff - US Patent 9,034,391, 2015 - Google Patents
The present invention relates to the use of pharmaceutically acceptable zinc salts, preferably
water soluble zinc salts alone or optionally, in combination with one or more of a protein …
water soluble zinc salts alone or optionally, in combination with one or more of a protein …
Fast acting inhibitor of gastric acid secretion with enhanced activity
JP Geibel - US Patent App. 15/128,049, 2017 - Google Patents
0002 The present invention relates to the surprising discovery that a hydrated Salt form of
Zinc, for example, Zinc chloride monohydrate, Zinc chloride dihydrate, Zinc chloride …
Zinc, for example, Zinc chloride monohydrate, Zinc chloride dihydrate, Zinc chloride …
Die gastroösophageale Refluxkrankheit und extraösophageale Erkrankungen: eine Langzeitbeobachtung im Rahmen der ProGERD-Studie
M Merschhemke - 2008 - refubium.fu-berlin.de
Hintergrund und Ziele Die gastroösophageale Refluxkrankheit (GERD) ist eine
weitverbreitete Krankheit. Sie kann mit verschiedenen extraösophagealen Erkrankungen …
weitverbreitete Krankheit. Sie kann mit verschiedenen extraösophagealen Erkrankungen …